Biodesix (BDSX) EBT Margin Growth (1y) (2020 - 2026)
Biodesix (BDSX) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 30.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 617.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 163.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 665.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -115.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 113.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -646.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 288.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -37.00 |
| 10 | Biodesix | 220.74 Mn | 195.16 Mn | 21.35 Mn | 2,700.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,700.00 |
| Dec 31, 2025 | 2,712.00 |
| Sep 30, 2025 | -5,031.00 |
| Jun 30, 2025 | -20,382.00 |
| Mar 31, 2025 | 3,119.00 |
| Dec 31, 2024 | 4,863.00 |
| Sep 30, 2024 | 3,231.00 |
| Jun 30, 2024 | 22,852.00 |
| Mar 31, 2024 | 62,230.00 |
| Dec 31, 2023 | 785.00 |
| Sep 30, 2023 | 22,215.00 |
| Jun 30, 2023 | 8,375.00 |
| Mar 31, 2023 | -45,402.00 |
| Dec 31, 2022 | 4,557.00 |
| Sep 30, 2022 | 6,061.00 |
| Jun 30, 2022 | -10,488.00 |
| Mar 31, 2022 | -10,994.00 |
| Dec 31, 2021 | -13,172.00 |
| Sep 30, 2021 | -27,686.00 |
| Jun 30, 2021 | -6,591.00 |